Authors: ry Van Beusekom | News Writer | CIDRAP News | Nov 08, 202 Myocarditis and pericarditis are rare after mRNA COVID-19 vaccination, but rates of the inflammatory heart conditions were […]
Censorship and Suppression of Covid-19 Heterodoxy: Tactics and Counter-Tactics
Authors: Yaffa Shir-Raz, Ety Elisha, Brian Martin, Natti Ronel & Josh uetzkow Minerva (2022) Minerva (2022) November 2, 2022 Abstract The emergence of COVID-19 has led to numerous controversies over COVID-related knowledge and policy. To counter the […]
Post-COVID Risk for Blood Clot Lasts at Least 6 Months
Authors: Robert Preidt HealthDay News April 7, 2022 COVID-19 increases people’s risk of dangerous blood clots and bleeding for months after infection, researchers say. The new findings suggest that COVID-19 is an […]
CDC Director Issues Alert On Pfizer’s COVID-19 Pill
Authors: Jack Phillips via The Epoch Times, JUN 01, 2022 Centers for Disease Control and Prevention Director Rochelle Walensky warned that Pfizer’s COVID-19 pill Paxlovid can lead to a rebound in symptoms. “If you […]
Coronavirus (COVID-19) Update: FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Vaccine Booster Dose to Children 5 through 11 Years
Authors: FDA May 18, 2022 Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster […]
Long-term cardiovascular outcomes of COVID-19
Authors: Yan Xie, Evan Xu, Benjamin Bowe & Ziyad Al-Aly Nature Medicine (2022)Cite this article368k Accesses Citations14239 AltmetricMetrics Abstract The cardiovascular complications of acute coronavirus disease 2019 (COVID-19) are well described, but the post-acute cardiovascular manifestations of […]
Moderna vs. Pfizer: Is There a “Best” mRNA Vaccine?
Both of the mRNA vaccines available in the US are highly effective against severe COVID-19, but recent studies suggest that Moderna’s elicits a stronger immune response and might be better […]